[1]MeliefCJM , KastWM .LessonsfromTcellresponsestovirus-inducedtumorsforcancereradicationingeneral[J].CancerSurv, 1992, 13∶81-89.
|
[2]Ruiz-CabelloF , GarridoF .HLAandcancer:fromresearchtoclinicalimpact[J].ImmunolToday, 1998, 19 (12) ∶539-542.
|
[3]CrommeFV , AireyJ, etal.Lossoftransporterprotein, encodedbytheTAP -1gene, ishighlycorrelatedwithlossofHLAexpressionincervicalcarcinomas[J].JExpMed, 1994, 179∶335-340.
|
[4]SungCH , HuCP , etal.ExpressionofclassⅠandclassⅡmajorhisto compatibilityantigensonhumanhepatocellularcarcinoma[J].JClinIn vest, 1989, 83 (2) ∶421-427.
|
[5]WadeeAA , PatersonA , etal.HLAexpressioninhepatocellularcarcino malines[J].ClinExpImmunol, 1994, 97 (2) ∶328-33.
|
[6]KurokohchiK , CarringtonM , etal.ExpressionofHLAclassⅠmoleculesandthetransporterassociatedwithantigenprocessinginhepato cellularcarcinoma[J].Hepatology, 1996, 23 (5) ∶1181-1188.
|
[7]ButterfieldLH , MengWS , etal.TcellresponsestoHLA -A 0201-restrictedpeptidesderivedfromhumanαfetoprotein[J].JImmunology, 2001, 166∶5300-5308.
|